CLOV vs SLS
Clover Health Investments Corp (CLOV) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$9.6M. SLS currently screens at market cap $1.62B.
CLOV currently screens at market cap $1.55B. SLS currently screens at market cap $1.62B.
Not investment advice. Open the CLOV and SLS stock pages for the full models.
Not investment advice.